|
The Substance Abuse and Mental
Health Services Administration today announced that persons seeking physicians
who can prescribe buprenorphine, a new prescription medication for addiction
to prescription pain relievers or heroin, can obtain information online
at buprenorphine.samhsa.gov
The online directory will be updated daily as physicians send their credentials to SAMHSA
and are issued an identification number by the Drug Enforcement Administration. Physicians
seeking information on how to receive training and become credentialed can call 1-866-287-2728.
SAMHSA will hold a series of 14 education forums, "New Paths to Recovery", to apprize
physicians and the public of the availability of buprenorphine to treat opiate abuse. Physicians
who obtain credentials from SAMHSA can treat their patients using buprenorphine.
SAMHSA is working with medical organizations including the American Society on Addiction
Medicine, the American Academy of Addiction Psychiatry and the American Osteopathic
Association to sponsor physician training on the use of buprenorphine in office-based settings to
treat addiction to opiates. These trainings will take place in the same metropolitan areas. The
first consumer education forum will be February 3 in Detroit at the Coleman A. Young municipal
center.
This will be followed by forums in the Wilmington, DE-Philadelphia region, Seattle, San
Juan, PR, New Orleans, Baltimore, Miami, San Francisco, Boston, Chicago, Salt=" " Lake City,
Portland, Dallas and the New York-Newark metropolitan area. Information on the seminars and
physician trainings is available at www.samhsa.gov
|
|
The Substance Abuse and Mental Health Services Administration, a public health agency within the U.S. Department of Health and Human Services, is the lead federal agency for improving the quality and availability of substance abuse prevention, addiction treatment and
mental health services in the United States. Information on SAMHSA's programs is available on
this website, www.samhsa.gov.
|